160896-45-7 | Hosenkoside F | C47H80 O19 |
160896-43-5 | a-L-xylo-3-Hexulofuranosidonicacid, b-D-glucopyranosyl2-C-[(1R)-1-(4-hydroxyphenyl)-3-methoxy-3-oxopropyl]-, g-lactone (9CI) | C22H28 O14 |
160896-57-1 | 9(1H)-Phenanthrenone,2,3,4,4a,10,10a-hexahydro-5,8-dihydroxy-6-methoxy-2,4a-dimethyl-1-methylene-7-(1-methylethyl)-,(2S,4aS,10aS)- | C21H28 O4 |
160896-51-5 | 2-Propenamide,N-[2-[4-[(3-methyl-2-buten-1-yl)oxy]phenyl]ethyl]-3-(methylsulfonyl)-, (2E)- | C17H23 N O4 S |
160896-49-1 | Hosenkoside K | C54H92 O25 |
160896-44-6 | a-L-xylo-3-Hexulofuranosidonicacid, b-D-glucopyranosyl2-C-[(1R)-2-carboxy-1-(4-hydroxyphenyl)ethyl]-, 1,4-lactone (9CI) | C21H26 O14 |
160896-53-7 | 2-Propenamide,N-[2-[4-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]phenyl]ethyl]-3-(methylsulfonyl)-,(2E)- | C22H31 N O4 S |
160896-39-9 | b-D-Glucopyranoside, (3b,6a,16b,24S)-3-[(2-O-acetyl-b-D-xylopyranosyl)oxy]-16,24,25-trihydroxy-9,19-cyclolanostan-6-yl | C43H72 O15 |
160896-52-6 | 2-Propenamide,N-methyl-N-[2-[4-[(3-methyl-2-buten-1-yl)oxy]phenyl]ethyl]-3-(methylsulfonyl)-,(2E)- | C18H25 N O4 S |
160896-42-4 | Spiro[furan-2(5H),3'(2'H)-furo[3,2-b]furan]-2',5-dione,3'a-(b-D-glucopyranosyloxy)hexahydro-6'-hydroxy-3-(4-hydroxyphenyl)-,(2S,3R,3'aR,6'S,6'aR)- (9CI) | C21H24 O13 |
160896-56-0 | 1,4-Methano-2-benzoxepin-8-ol,1,3,4,5-tetrahydro-10-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methoxy-,(1R,4R,10R)- | C20H22 O5 |
160896-54-8 | 2-Propenamide,N-[2-[4-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]phenyl]ethyl]-N-methyl-3-(methylsulfonyl)-,(2E)- | C23H33 N O4 S |
160896-55-9 | 2-Propenamide,N-[2-[4-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octen-1-yl]oxy]phenyl]ethyl]-3-(methylsulfonyl)-,(2E)-(-)- | C22H33 N O6 S |
160896-46-8 | Hosenkoside G | C47H80 O19 |